FDA approves changes to Spectral's septic shock trial

(Reuters) - Spectral Diagnostics Inc said the U.S. health regulator approved a change in the design of a late-stage trial of its therapy for septic shock, to increase the study's ability to detect the treatment's effects. The trial, named ...

Source: http://health.yahoo.net/news/s/nm/fda-approves-changes-to-spectral-s-septic-shock-trial

writing Jesus Receipt design John Edwards